Allergic Conjunctivitis
📧 Sign up to get email alerts when something new happens for Allergic Conjunctivitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: A Study to Demonstrate the Effect of REGN5713-5715 on Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Birch Pollen Allergy [Phase 3]
Phase 3 study evaluating REGN5713-5715 for reducing signs and symptoms of ocular allergy in adults with birch pollen allergy (allergic conju…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy [Phase 3]
A Phase 3 study evaluating Bet v1 antibodies for eye allergy symptoms in adolescents and adults with birch pollen allergy. The trial is curr…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: OJO-miR: microRNA Expression in Allergic Conjunctivitis.
The OJO-miR study investigates microRNA expression in allergic conjunctivitis and is listed as active but not recruiting.
-
FDA approval · 2026-01-30FDA Approved: CETIRIZINE HCL — Supplemental Application (AMERISOURCE BERGEN)
The FDA approved a supplemental application for cetirizine hydrochloride, submitted by Amerisource Bergen.
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: The Effects of Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops Compared to Placebo [NA]
The clinical trial comparing Ectoin Allergy Nasal Spray and Ectoin Allergy Eye Drops to placebo has completed. It studied allergic rhinitis …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Tyrosine Allergoid Paediatric and Adult Study
This update reports the Tyrosine Allergoid pediatric and adult trial sponsored by Allergy Therapeutics, studying allergic rhinitis due to po…
-
EMA approval · 2026-01-22EMA Authorised: Opatanol (olopatadine hydrochloride) — Novartis Europharm Limited
EMA authorised Opatanol (olopatadine hydrochloride) for allergic conjunctivitis, with Novartis Europharm Limited as the marketing authorisat…
-
FDA approval · 2026-01-06FDA Approved: EYE ALLERGY ITCH RELIEF — Original Application (Dr. Reddy's Laboratories Inc.)
FDA approved the original ANDA for Eye Allergy Itch Relief containing olopatadine hydrochloride ophthalmic solution, a generic version of an…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Kelulut Honey for Allergic Conjunctivitis and Dry Eye Symptoms [NA]
A Universiti Sains Malaysia-sponsored clinical trial is evaluating kelulut honey for dry eye symptoms and allergic conjunctivitis in both ey…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Evaluation of TL-925 for the Treatment of Seasonal Allergic Conjunctivitis [Phase 2]
Phase 2 clinical trial evaluating TL-925 for seasonal allergic conjunctivitis is currently recruiting.
-
FDA label_change · 2025-10-22FDA Approved: VISINE ALLERGY EYE RELIEF MULTI-ACTION — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application to update the labeling for VISINE ALLERGY EYE RELIEF MULTI-ACTION, a combination eye drop containing…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Phleum Pratense and Dactylis Glomerata Allergen Extracts Standardization [NA]
A completed clinical trial from Inmunotek S.L. focusing on standardizing Phleum pratense and Dactylis glomerata allergen extracts for pollen…
-
FDA approval · 2025-09-23FDA Approved: FLAREX — Supplemental Application (Eyevance Pharmaceuticals)
The FDA granted a supplemental approval for FLAREX (fluorometholone acetate) by Eyevance Pharmaceuticals. The notice indicates FDA approval …
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Treg Effector Function and Th2/Treg Ratio in Allergic Conjunctivitis: Effect of Desensitization Therapy
A clinical trial investigating how desensitization therapy affects regulatory T cell function and the Th2/Treg balance in allergic conjuncti…
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Safety and Efficacy of VSJ-110 in the Treatment of Allergic Conjunctivitis in Adults With a History of Ocular Allergies [Phase 2]
Phase 2 trial results for VSJ-110 in adults with allergic conjunctivitis, reporting safety and efficacy data. Results have been posted.
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Quality of Life In Patients With Allergic Conjunctivitis In Treatment With Sublingual Allergen Immunotherapy In A Referral Ophthalmological Hospital
This clinical trial update examines quality of life outcomes in patients with allergic conjunctivitis treated with sublingual allergen immun…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: A Study to Demonstrate How Well REGN1908-1909 Works in Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Cat Allergy [Phase 3]
This update confirms the completion of a Phase 3 study evaluating REGN1908-1909 for reducing ocular allergy signs and symptoms in adults wit…
-
FDA approval · 2025-08-29FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for cetirizine hydrochloride from Rising Pharma Holdings, Inc., indicating an update to the approved…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: Documentation of Efficacy of Intralymphatic Allergen Immunotherapy [Phase 3]
Phase 3 clinical trial has completed and documents the efficacy of intralymphatic allergen immunotherapy for grass pollen–related allergic r…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: Noninterventional Study on Tolerability and Safety of One Strength Updosing With Novo-Helisen Depot House Dust Mites
Noninterventional study update assessing tolerability and safety of a single-strength updosing with Novo-Helisen Depot for house dust mite–r…
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: Clinical and Biological Evaluation of NAAGA Versus Azelastine Eye Drops in Allergic Subjects With Tear Film Dysfunction [Phase 4]
Phase 4 clinical trial comparing NAAGA to azelastine eye drops in subjects with allergic conjunctivitis and tear film dysfunction has been c…
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution [Phase 3]
A Phase 3 trial evaluating the safety and pharmacokinetics of a fixed-dose combination Brimonidine tartrate 0.025% and Ketotifen fumarate 0.…
-
FDA approval · 2025-06-24FDA Approved: PROMETHAZINE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for promethazine hydrochloride from Hikma Pharmaceuticals USA, confirming the approval of a generic …
-
FDA approval · 2025-05-20FDA Approved: LOTEPREDNOL ETABONATE — Original Application (Amneal Pharmaceuticals NY LLC)
The FDA approved the original application for Loteprednol etabonate ophthalmic drops from Amneal Pharmaceuticals NY LLC, providing a generic…
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of a treatment for grass and olive pollen allergy is currently recruiting, targeti…